Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SAMA Stock Summary
In the News

CLVR Stock: 12 Things to Know as Cannabis Play Clever Leaves Starts Trading
CLVR stock will start trading on the Nasdaq today after Clever Leaves completed its SPAC merger with Schultze Special Purpose Acquisition. The post CLVR Stock: 12 Things to Know as Cannabis Play Clever Leaves Starts Trading appeared first on InvestorPlace.

3 Cannabis SPACs To Consider For 2021
SPACs have been one of the hottest investment stories of 2020. The blank check, reverse merger vehicles have taken numerous private companies — as well as former public companies — public on major exchanges.

7 Marijuana Stocks Hoping 2021 Brings Federal Legalization
The improving regulatory landscape for marijuana stocks could usher in a boom, particularly for companies focused on the U.S. market. The post 7 Marijuana Stocks Hoping 2021 Brings Federal Legalization appeared first on InvestorPlace.

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc. to Participate in SPACInsider Webinar on November 16 at 1:00 p.m. ET
Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation

Schultze Special Purpose Acquisition Corp. and Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, Announce Revised Transaction Terms
Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET
SAMA Financial details
SAMA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | |
Net income per share | 0.49 | -0.09 | -0.06 | |
Operating cash flow per share | -0.28 | -0.11 | -0.08 | |
Free cash flow per share | -0.28 | -0.11 | -0.08 | |
Cash per share | 0.16 | 0.15 | 10.25 | |
Book value per share | 36.28 | 21.5 | 9.73 | |
Tangible book value per share | 36.28 | 21.5 | 9.73 | |
Share holders equity per share | 36.28 | 21.5 | 9.73 | |
Interest debt per share | -0.8 | 0 | -0.16 | |
Market cap | 35.92M | 73.91M | 166.65M | |
Enterprise value | 35.33M | 72.8M | 166.28M | |
P/E ratio | 19.82 | -110.75 | -181.01 | |
Price to sales ratio | 0 | 0 | 0 | |
POCF ratio | -34.53 | -89.41 | -133.44 | |
PFCF ratio | -34.53 | -89.41 | -133.44 | |
P/B Ratio | 0.27 | 0.46 | 1.04 | |
PTB ratio | 0.27 | 0.46 | 1.04 | |
EV to sales | 0 | 0 | 0 | |
Enterprise value over EBITDA | 15.4 | -103.73 | -36.76 | |
EV to operating cash flow | -33.96 | -88.07 | -133.15 | |
EV to free cash flow | -33.96 | -88.07 | -133.15 | |
Earnings yield | 0.05 | -0.01 | -0.01 | |
Free cash flow yield | -0.03 | -0.01 | -0.01 | |
Debt to equity | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | |
Net debt to EBITDA | -0.26 | 1.58 | 0.08 | |
Current ratio | 3.17 | 5.11 | 0.22 | |
Interest coverage | 0.22 | 0 | 1.17 | |
Income quality | -0.57 | 1.21 | 1.36 | |
Dividend Yield | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | |
Graham number | 20.1 | 6.56 | 3.49 | |
ROIC | 0 | 0 | -0.04 | |
Return on tangible assets | 0.01 | 0 | -0.01 | |
Graham Net | 0.1 | -0.77 | 9.72 | |
Working capital | 459.82K | 1.26M | -1.71M | |
Tangible asset value | 132.85M | 161.44M | 160.52M | |
Net current asset value | 458.59K | -5.34M | -8.31M | |
Invested capital | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | |
Average payables | 0 | 0 | 939.1K | |
Average inventory | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | |
ROE | 0.01 | 0 | -0.01 | |
Capex per share | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.07 | 0.02 | 51.98K | 0.04 | 0.1 | |
Operating cash flow per share | -0.01 | -0.01 | -23.25K | -0.01 | -0.1 | |
Free cash flow per share | -0.01 | -0.01 | -23.25K | -0.01 | -0.1 | |
Cash per share | 8.12 | 8.15 | 9.95M | 8.28 | 12.64 | |
Book value per share | 7.72 | 7.74 | 9.44M | 7.82 | 9.97 | |
Tangible book value per share | 7.72 | 7.74 | 9.44M | 7.82 | 9.97 | |
Share holders equity per share | 7.72 | 7.74 | 9.44M | 7.82 | 9.97 | |
Interest debt per share | -0.01 | -0.04 | 2.26K | -0.09 | 0.1 | |
Market cap | 202.95M | 205.01M | 171.7 | 212.23M | 43.19M | |
Enterprise value | 202.46M | 204.44M | -366.62K | 212M | 43.05M | |
P/E ratio | -34.14 | 163.74 | 0 | 71.26 | 25.45 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -902.57 | -1.04K | 0 | -1.02K | -105.1 | |
PFCF ratio | -902.57 | -1.04K | 0 | -1.02K | -105.1 | |
P/B Ratio | 1.27 | 1.28 | 0 | 1.32 | 1.05 | |
PTB ratio | 1.27 | 1.28 | 0 | 1.32 | 1.05 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -102.28 | -507.14 | 0.21 | -319.78 | -221.16 | |
EV to operating cash flow | -900.4 | -1.04K | 0.93 | -1.02K | -104.77 | |
EV to free cash flow | -900.4 | -1.04K | 0.93 | -1.02K | -104.77 | |
Earnings yield | -0.01 | 0 | 5.15K | 0 | 0.01 | |
Free cash flow yield | 0 | 0 | -2.3K | 0 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.01 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.01 | |
Net debt to EBITDA | 0.25 | 1.42 | 0.21 | 0.34 | 0.69 | |
Current ratio | 0.46 | 0.39 | 0.22 | 0.08 | 0.13 | |
Interest coverage | 7.87 | 0.44 | -8.84 | 0.37 | 0 | |
Income quality | 0.13 | -0.63 | -0.45 | -0.28 | -0.97 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.54 | 1.63 | 3.32M | 2.52 | 4.8 | |
ROIC | -0.01 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.01 | 0 | 0.01 | 0 | 0.01 | |
Graham Net | 7.71 | 7.73 | 9.44M | 7.82 | 9.96 | |
Working capital | -994.24K | -1.26M | -1.71M | -2.66M | -3.88M | |
Tangible asset value | 159.33M | 159.64M | 160.52M | 161.27M | 41.11M | |
Net current asset value | -7.59M | -7.86M | -8.31M | -9.26M | -10.48M | |
Invested capital | 0 | 0 | 0 | 0 | 0.01 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.05M | 1.88M | 1.89M | 2.06M | 2.16M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.01 | 0 | 0.01 | 0 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SAMA Frequently Asked Questions
What is Schultze Special Purpose Acquisition Corp. II stock symbol ?
Schultze Special Purpose Acquisition Corp. II is a US stock , located in Rye brook of Ny and trading under the symbol SAMA
What is Schultze Special Purpose Acquisition Corp. II stock quote today ?
Schultze Special Purpose Acquisition Corp. II stock price is $10.6 today.
Is Schultze Special Purpose Acquisition Corp. II stock public?
Yes, Schultze Special Purpose Acquisition Corp. II is a publicly traded company.